Partially offsetting these positive contributors was stock selection in the industrials and health care sectors, which detracted. In industrials, the Fund was hurt most by having an overweighted allocation to the sector, which lagged the S&P 500® Index during the semi-annual period. Most notably, the Fund overweighted the railroad industry, wherein positions in Canadian National Railway, Kansas City Southern and Union Pacific declined. Health care was the strongest sector in the S&P 500® Index during the semi-annual period. The Fund was prudently overweighted, but having an overweight position in life science equipment provider Idexx Laboratories, whose shares declined, dampened performance. Not owning a position in biopharmaceutical company Gilead Sciences also hurt, as its shares rose.
What were some of the Fund’s best-performing individual stocks?
Among the individual stocks that contributed most to the equity portion of the Fund’s relative results were automotive parts and accessories retailer O’Reilly Automotive, pharmaceuticals company Novo Nordisk and lighting and control systems producer Acuity Brands, which each saw its share price gain driven by strong operating results. Other especially strong performers during the semi-annual period included weighing instruments manufacturer Mettler-Toledo International, application software provider Salesforce.com, and, among those stocks already mentioned, Reynolds American and Cognizant Technology Solutions.
Which stocks detracted significantly from the Fund’s performance during the semi-annual period?
During the semi-annual period, the Fund was hurt by profit-taking in the railroad industry, where weaker than expected operating results sent the shares of Canadian National Railway, Kansas City Southern and Union Pacific, in each of which the Fund held a position, down. As mentioned earlier, Idexx Laboratories was also a weak performer during the semi-annual period, struggling as it reported weaker than expected quarterly earnings. Not holding a position in the strongly performing information technology giant Apple detracted as well.
Did the equity portion of the Fund make any significant purchases or sales?
During the semi-annual period, we initiated a position in the equity portion of the Fund in specialty consumer finance company Fiserv, which produced better than expected operating results and which has a consistent long-term record of strong earnings and stock price growth.
Deletions from the Fund’s equity portfolio included three financial companies—supplemental insurance company Aflac, diversified financial services company Royal Bank of Canada and financial services holding company T Rowe Price Group. In each case, we sold the Fund’s position due to eroding long-term growth rates in earnings and stock price.
Were there any notable changes in the equity portion of the Fund’s weightings during the six-month period?
There were no material changes in the equity portion of the Fund’s sector weightings during the six-month period ended June 30, 2015.
How was the equity portion of the Fund positioned relative to its benchmark index at the end of June 2015?
As of June 30, 2015, the Fund was overweighted relative to the S&P 500® Index in the industrials, materials and health care sectors. The Fund was underweighted relative to the S&P 500® Index in the information technology, financials and energy sectors on the same date.
What was the duration strategy of the fixed income portion of the Fund?
Duration positioning in the fixed income portion of the Fund had a positive effect on its performance relative to the Barclays Index during the reporting period. We kept the Fund’s duration short that of the Barclays Index by approximately 1/2 year, which helped, as rates generally rose. Duration is a measure of the Fund’s sensitivity to changes in interest rates.
Which fixed income market segments most significantly affected Fund performance?
The fixed income portion of the Fund’s position in and issue selection among corporate bonds, both investment grade and high yield, was the strongest positive contributor to its relative performance. Investors were attracted to their relatively higher yields in a time of still relatively low rates. The biggest detractors from the fixed income portion of the